Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Debt Issued

Bristol-Myers Squibb Company Debt Issued Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Debt Issued from 2010 to 2020.
  • Bristol-Myers Squibb Company Debt Issued for the quarter ending June 06, 2020 was $-26m a 219.23% decrease of -57m year over year
  • Bristol-Myers Squibb Company Debt Issued for the last 12 months ending September 09, 2020 was $8,004m a -236.19% decrease of -18,905m year over year
  • Bristol-Myers Squibb Company Annual Debt Issued for 2019 was $26,909m a 91.77% increase of 24,694m from 2018
  • Bristol-Myers Squibb Company Annual Debt Issued for 2017 was $2,215m a 94.36% increase of 2,090m from 2016
  • Bristol-Myers Squibb Company Annual Debt Issued for 2016 was $125m a -914.40% decrease of -1,143m from 2015
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2018 was $1,279m a 12.67% increase of 162m year over year
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $628m a -33.89% decrease of -213m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Debt Issued Data

06/2020$-26m
03/2020$26m
12/2019$8,004m
09/2019$31m
06/2019$18,874m
12/2017$-471m
09/2017$898m
06/2017$108m
03/2017$1,680m
12/2016$23m

Annual BMY Debt Issued Data

2019$26,909m
2017$2,215m
2016$125m
2015$1,268m
2014$244m
2013$1,687m
2012$1,999m
2010$6m